Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2009.136 | Role of Beta-arrestin in HIV infection and heroin addiction | DR Chen Yangchao |
| 2014.619 | Role of auriculotherapy as an adjunct treatment during detoxification among patients with substance misuse problems: A pilot study | Ms Lee Miu Kuen |
| 2007.459 | Role of Atrioventricular Nodal Ablation in Patients with Chronic Atrial Fibrillation for Cardiac Resynchronization Therapy | Dr. Fung Wing Hong |
| 2005.026 | Role of Adhesion Molecules and Chemokines in Patients with Community Acquired Pneumonia and Severe Acute Respiratory Syndrome | RAINER Timothy Hudson |
| 2011.188 | Role of a novel RING finger Tumor Suppresor RNF180 in oncoprotein ubiquitylation/degradation and signaling | Prof Tao Qian |
| 2006.103 | Role and Small Non-Coding miR-221 and miR-222 in the Oncogensis of Human Hepatocellular Carcinoma | WONG Nathalie |
| 2012.448 | Role and reguatory signals of novel genes RGS1 and RGS13 in the homing and engraftment of human hematopoietic stem/progenitor cells for bone marrow immunologic reconstitution | Dr. LI Chi Kong |
| 2021.102 | Role and mechanisms of TUBB2B in promoting brain metastatic outgrowth of breast cancer |
Prof. TSE Gary Man-Kit 謝文杰 |
| 2016.133 | Robust T1rho magnetic resonance imaging of liver on human subjects |
Prof. CHEN Weitian 陈蔚天 |
| 2020.571 | Robotic Technology and Digital Health Applications in Primary Care | Prof. WONG Samuel |
| 2020.019 | Robotic Radical Perineal Prostatectomy for Localized Prostate Cancer: A Feasibility Study |
Dr. YEE Chi Hang 余知行 |
| 2023.135 | ROBI Project: Community-Based Holistic Service Supporting At-Risk Families with Age 0-2 Children |
Prof. YIP Virginia Choy Yin 葉彩燕 |
| 2021.210 | RNA N6-methyladenosine methyltransferase-like 3 (METTL3) is a potential therapeutic target for immunotherapy in colorectal cancer | Dr. CHEN Huarong |
| 2023.022 | RNA N6-Methyladenosine Demethylase AlkB Homolog 5 (ALKBH5) promotes stemness and chemoresistance in colorectal cancer: mechanism and novel therapeutic approaches |
Prof. YU Jun 于君 |
| 2022.026 | RNA N6-Methyladenosine (m6A) Methyltransferase METTL3 facilitates non-alcoholic fatty liver disease-associated hepatocellular carcinoma (NAFLDHCC) via a m6A-cholesterol axis to repress T-cell function |
Prof. YU Jun 于君 |
| 2022.108 | RNA m6A甲基化识别蛋白YTHDF1在调控结直肠癌免疫微环境中的作用及机制研究 (Elucidating the role and mechanism of RNA m6A reader YTHDF1 in regulating the immune microenvironment of colorectal cancer) |
Prof. YU Jun 于君 |
| 2023.114 | RNA m6A去甲基化酶ALKBH5对结直肠癌化疗疗效的影响及作用机制 (Targeting RNA m6A eraser ALKBH5 boosts the efficacy of chemotherapy in colorectal cancer) |
Prof. YU Jun 于君 |
| 2020.684 | RNA Demethylase AlkB Homolog 5 (ALKBH5) drives immune suppression in colorectal cancer via epitranscriptome regulation of AXIN2-WNT-DKK1 axis |
Prof. YU Jun 于君 |
| 2015.153 | Rivastigmine for cognitive impairment after aneurysmal subarachnoid hemorrhage: a randomized placebo-controlled clinical trial. | Prof. WONG George Kwok Chu |
| 2020.113 | Risks of serious infections and opportunistic infections in patients on immunosuppressive and biological modifier therapies – a population-based study |
Prof. MAK Wing Yan 麥詠欣 |
| 2012.168 | Risk-benefit evaluation of the introduction of a rotavirus vaccine into the Hong Kong Child Immunisation Programme | Professor Nelson Edmund Anthony |
| 2017.591 | Risk stratification of TIA or minor stroke using artificial neural network | Dr. LENG Xinyi |
| 2024.424 | Risk stratification of acid suppressant-related major adverse events in Asians: a retrospective cohort study | Prof. HUANG Junjie |
| 2007.354 | Risk Stratification in Inter-Facility Transport of Upper Gastrointestinal Bleeding Patients | LEUNG Sasi Choi Patrick |
| 2015.391 | Risk stratification for hypertension patients incorporating both clinical and automatic retinal image analysis outcomes |
Prof. ZEE Benny Chung Ying 徐仲鍈 |
| 2006.175 | Risk Stratification for Active Pulmonary Tuberculosis Using Whole Blood Interferon-y Assay | COCKRAM CS |
| 2021.525 | Risk screening for prodromal Parkinson’s disease in elderly using smartphone | Dr. HUANG Bei |
| 2009.043 | Risk Predictors of Vascular Complication after Diagnostic Cardiac Cathetherization and Percutaneous Coronary Interventions | CHENG Kit Yan |
| 2013.262 | Risk perception in paranoid delusions and generalised anxiety disorder | Ms. CHAN Gloria Hoi Kei |
| 2007.275 | Risk of Tuberculosis in Patients with Rheumatoid Arthritis in Hong Kong | TAM Lai Shan |
| 2020.707 | Risk of self-harm after the diagnosis of psychiatric disorders in Hong Kong: a retrospective study |
Prof. TANG Wai Kwong 鄧偉光 |
| 2020.527 | Risk of radiation-induced ocular complications after radiotherapy for nasopharyngeal carcinoma: A retrospective cross sectional cohort study | Dr. CHAN Ching Yan |
| 2017.335 | Risk of post colonoscopic polypectomy bleeding in patients on anti-platelets and anti-coagulant – case control study | Dr. LAU Louis Ho Shing |
| 2024.373 | Risk of non-arteritic anterior ischemic optic neuropathy with glucagon-like peptide-1 receptor agonist – a territory-wide study | Dr. Ip Yiu Ming Bonaventure |
| 2012.570 | Risk of Intracerebral Haemorrhage in Patients Taking Oral Anticoagulants for Atrial Fibrillation with Cerebral Microbleeds. A Prospective Study in Warfarin. (IPAAC-Warfarin Study) | Dr. SOO Yannie Oi Yan |
| 2014.419 | Risk of Intracerebral Haemorrhage in Patients Taking Oral Anticoagulants for Atrial Fibrillation with Cerebral Microbleeds. A Prospective Study in Warfarin - Phase II Study. (IPAAC-Warfarin Phase II Study) | Dr. SOO Yannie Oi Yan |
| 2014.359 | Risk of Intracerebral Haemorrhage in Patients Taking Oral Anticoagulants for Atrial Fibrillation with Cerebral Microbleeds. A Prospective Study in Novel Oral Anticoagulants. (IPAAC-NOAC Study) | Dr. SOO Yannie O.Y. |
| 2017.214 | Risk of hepatocellular carcinoma in patients with chronic hepatitis B achieved complete viral suppression – role of on-treatment hepatitis B surface/core-related antigen (HBsAg/HBcrAg) levels |
Dr. WONG Grace Lai Hung 黃麗虹 |
| 2020.079 | Risk of hepatitis flare in patients with previous hepatitis B virus exposure amongst patients on immunosuppressive and biological modifier therapies |
Prof. MAK Wing Yan 麥詠欣 |
| 2016.479 | Risk of gastrointestinal bleeding in patients with non-ST elevation myocardial infarction and treated with double anti-platelet and anti-coagulation therapies: a retrospective analysis |
Dr. TSANG Chiu Chung 曾招聰 |
| 2021.487 | Risk of bleeding complications in patients on oral anticoagulants: a population-based study | Dr LAU Louis Ho Shing |
| 2017.386 | Risk of anti-tuberculous drug-induced hepatotoxicity in patients with chronic hepatitis B infection: impact of antiviral therapy |
Dr. LUI Grace Chung Yan 雷頌恩 |
| 2012.216 | Risk of advanced colorectal neoplasm in patients with non-alcoholic fatty liver disease | CHAN Lik Yuen Henry |
| 2011.090 | Risk index for screening subclinical brian lesions in communitydwelling elderly persons in Hong Kong | Prof. MOK Vincent Chung Tong |
| 2008.341 | Risk Factors of Community Associated Methicillin Resistant Stapylococcus Aureus Infection in Hong Kong | Dr. Lai Wai Man |
| 2006.189 | Risk Factors of Breast Cancer in Chinese: Genetic, Pathology and Epidemiology Study | TANG Leung Sang Nelson |
| 2010.412 | Risk factors of ankle ligamentos sprain and hamstring strain in Hong Kong peofessional soccer players | Prof Fong Daniel Tik-Pui |
| 2017.050 | Risk factors for treatment failure in patients with cellulitis in an emergency medicine ward in Hong Kong: a retrospective cohort study |
Dr. LEUNG Michael Hou Jiu 梁顥耀 |
| 2019.145 | Risk factors for treatment failure and recurrence after metronidazole and vancomycin treatment for Clostridium difficile infection in Hong Kong | Dr. TSANG Chi Wo |
| 2022.366 | Risk factors for susceptibility, severity and prognosis of inflammatory myopathies | Dr. SO Ho |
Page 52 of 264.